- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GNI Group Ltd (2160)
GNI Group Ltd stock price live, this page displays TYO 2160 stock exchange data. View the 2160 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GNI Group Ltd real time stock price chart below.
What Is the GNI Group Ltd Stock Price Today?
The GNI Group Ltd stock price today is 3,115.0.
What Is the Stock Symbol for GNI Group Ltd?
The stock symbol for GNI Group Ltd is "2160."
What Stock Exchange Does GNI Group Ltd Trade On?
GNI Group Ltd is listed and trades on the Tokyo stock exchange.
Is GNI Group Ltd a Good Stock to Buy?
Determining whether GNI Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2160 quote. (ISIN: JP3386370005)
What Is the GNI Group Ltd Stock Price Today?
The GNI Group Ltd stock price today is 3,115.0.
What Is the Stock Symbol for GNI Group Ltd?
The stock symbol for GNI Group Ltd is "2160."
What Stock Exchange Does GNI Group Ltd Trade On?
GNI Group Ltd is listed and trades on the Tokyo stock exchange.
Is GNI Group Ltd a Good Stock to Buy?
Determining whether GNI Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2160 quote. (ISIN: JP3386370005)
3,115.0
-60.0(-1.89%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,090.0
3,165.0
52 wk Range
1,537.0
3,865.0
2160 Scorecard
Full Analysis
Prominent player in the Biotechnology industry
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,090.03,165.0
52 wk Range
1,537.03,865.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2160 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Analysts Sentiment
Strong Buy
Price Target
3,850.0
Upside
+23.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
GNI Company Profile
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase III clinical trial for the treatment of liver fibrosis; and F573 that is in phase II for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.
Compare 2160 to Peers and Sector
Metrics to compare | 2160 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2160PeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.7x | −5.6x | −0.6x | |
PEG Ratio | 0.06 | −0.19 | 0.00 | |
Price/Book | 4.7x | 3.9x | 2.6x | |
Price / LTM Sales | 6.9x | 76.2x | 3.1x | |
Upside (Analyst Target) | 23.6% | 52.5% | 53.0% | |
Fair Value Upside | Unlock | 13.8% | 8.0% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3,850.0
(+23.60% Upside)
Earnings
Latest Release
Nov 14, 2024
EPS / Forecast
19.51 / 13.04
Revenue / Forecast
5.46B / 6.17B
FAQ
What Is the GNI (2160) Stock Price Today?
The GNI stock price today is 3,115.00.
What Stock Exchange Does GNI Trade On?
GNI is listed and trades on the Tokyo stock exchange.
What Is the Stock Symbol for GNI?
The stock symbol for GNI is "2160."
What Is the GNI Market Cap?
As of today, GNI market cap is 156.21B.
What is GNI Earnings Per Share?
The GNI EPS is 144.84.
What Is the Next GNI Earnings Date?
GNI will release its next earnings report on 13 Feb 2025.
From a Technical Analysis Perspective, Is 2160 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.